Neasa Hourigan (Dublin Central, Green Party) | Oireachtas source

Is there, or has there been, a concern, even with that European requirement, with regard to the interaction with the competitiveness of particular products? Pharma is a private industry and if it is reporting shortages I can only imagine that that might have an impact. Is there a concern in terms of the legislation as to how it interacts with the pharma industry's private operation as profit-driven companies?